A6QP70
Gene name |
SGCB |
Protein name |
Beta-sarcoglycan |
Names |
Beta-SG |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:535372 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for A6QP70
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A6QP70-F1 | Predicted | AlphaFoldDB |
33 variants for A6QP70
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs441612272 | 72 | F>L | No | EVA | |
| rs478807066 | 110 | K>N | No | EVA | |
| rs458776115 | 114 | D>A | No | EVA | |
| rs476772409 | 115 | M>L | No | EVA | |
| rs462888493 | 116 | G>R | No | EVA | |
| rs476707637 | 117 | V>A | No | EVA | |
| rs476707637 | 117 | V>D | No | EVA | |
| rs442833160 | 117 | V>F | No | EVA | |
| rs454285869 | 118 | I>R | No | EVA | |
| rs723939321 | 148 | G>R | No | EVA | |
| rs437334418 | 155 | G>E | No | EVA | |
| rs470390249 | 165 | T>I | No | EVA | |
| rs517972538 | 218 | K>E | No | EVA | |
| rs714144964 | 224 | I>T | No | EVA | |
| rs482114208 | 246 | M>V | No | EVA | |
| rs719788081 | 253 | S>N | No | EVA | |
| rs459491514 | 254 | I>S | No | EVA | |
| rs470768298 | 255 | I>S | No | EVA | |
| rs439337350 | 255 | I>V | No | EVA | |
| rs457171405 | 258 | G>R | No | EVA | |
| rs443678707 | 259 | T>P | No | EVA | |
| rs443678707 | 259 | T>S | No | EVA | |
| rs475122162 | 260 | V>G | No | EVA | |
| rs133517738 | 264 | T>M | No | EVA | |
| rs434782386 | 269 | S>G | No | EVA | |
| rs472843806 | 282 | V>A | No | EVA | |
| rs472843806 | 282 | V>G | No | EVA | |
| rs452722858 | 285 | K>N | No | EVA | |
| rs461699370 | 288 | M>T | No | EVA | |
| rs470360161 | 310 | D>H | No | EVA | |
| rs450289923 | 311 | N>T | No | EVA | |
| rs386029530 | 312 | P>A | No | EVA | |
| rs468119864 | 317 | Y>S | No | EVA |
No associated diseases with A6QP70
No regional properties for A6QP70
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for A6QP70 | |||
5 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| sarcoglycan complex | A protein complex formed of four sarcoglycans plus sarcospan; there are six known sarcoglycans: alpha-, beta-, gamma-, delta-, epsilon- and zeta-sarcoglycan; all are N-glycosylated single-pass transmembrane proteins. The sarcoglycan-sarcospan complex is a subcomplex of the dystrophin glycoprotein complex, and is fixed to the dystrophin axis by a lateral association with the dystroglycan complex. |
| sarcolemma | The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| muscle organ development | The process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAAAAAATEQ | QSSNGPVKKS | MREKAVERRN | VNKEHNSNFK | AGYIPIDEDR | LHKTGLRGRK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GNLAICVIVL | LFILAVINLI | ITLVIWAVIR | IGPNGCDSME | FHESGLLRFK | QVSDMGVIHP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LYKSTVGGRR | NENLVITGNN | QPIVFQQGTT | KLSVGKNKTS | ITSDTGMQFF | DPRTQNILFS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| TDYETHEFHL | PSGVKSLNVQ | KASTERITSN | ATSDLNIKVG | GRAIVRGNEG | VFIMGKTIQF |
| 250 | 260 | 270 | 280 | 290 | 300 |
| HMGGNMELKA | ENSIILNGTV | MVSTNRLPSS | SSGDQFGGDD | WVRYKLCMCA | DGTLFRVQVT |
| 310 | |||||
| GQNMGCQTSD | NPCGDLY |